Related Articles
Expression of genes and their responses to enzyme replacement therapy in a Fabry disease mouse model
Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease
Blockade of vascular endothelial growth factor-A/receptor 2 exhibits a protective effect on angiotensin-II stimulated podocytes
Accumulation of VEGFR2 in zoledronic acid-treated endothelial cells
Tacrolimus but not cyclosporine A enhances FGF-2-induced VEGF release in osteoblasts